Deal Tracker · Regions
CIS & Central Asia pharma deals
10 pharma deals in CIS & Central Asia tracked by EPT — localization, investment & joint ventures. Most active: Kazakhstan Ministry of Health, Abdi İbrahim, Abdi Ibrahim Global Pharm & AltINFARM. Latest: Sanofi → Nobel AFF (Technology transfer / Localization, 26 Oct 2026).
- Sanofi → Nobel AFFTechnology transfer / Localization · CIS & Central Asia · Undisclosed · 26 Oct 2026
- Gen İlaç → Azerbaijan Business Development FundJoint venture · CIS & Central Asia · $67m · 5 Oct 2026
- KyungDong Pharmaceutical → Kazakhstan Ministry of HealthPartnership / Collaboration · CIS & Central Asia · Undisclosed · 14 Sept 2026
- Kazakhstan Ministry of Health → Steppe PharmaceuticalsTechnology transfer / Localization · CIS & Central Asia · $71m · 26 May 2026
- Kazakhstan Ministry of Health → Karaganda Pharmaceutical ComplexTechnology transfer / Localization · CIS & Central Asia · $89.7m · 15 May 2026
- EBRD → Samarkand England Eco-Medical & Bayan MedicalEquity / Investment · CIS & Central Asia · Up to €20 million · 26 Feb 2026
- Abdi İbrahim → Abdi Ibrahim Global PharmTechnology transfer / Localization · CIS & Central Asia · $83m · 22 Jan 2026
- World Medicine & Rompharm → MSP-ROMPHARMTechnology transfer / Localization · CIS & Central Asia · $78m · 22 Jan 2026
- Nobel İlaç → Nobel Almaty Pharmaceutical FactoryTechnology transfer / Localization · CIS & Central Asia · $84m · 22 Jan 2026
- Sinopharm, Sinovac & Kangtai Biological Technology → AltINFARMTechnology transfer / Localization · CIS & Central Asia · $125m · 22 Jan 2026
Browse deals
By region
MENA (53) · GCC (48) · Africa (14) · Southeast Asia (8) · Global (LMICs) (5) · Türkiye (4) · Global ex-US (1)
By deal type
Licensing (38) · Distribution (25) · Technology transfer / Localization (23) · Partnership / Collaboration (22) · M&A / Acquisition (16) · Equity / Investment (7) · Joint venture (5) · Supply / Manufacturing (5)
By company
ADCAN Pharma (11) · Mubadala Bio (8) · Hikma Pharmaceuticals (6) · Jamjoom Pharma (6) · Bio-Thera Solutions (5) · Avalon Pharma (4) · SPIMACO (4) · Groupe Saidal (4) · Department of Health – Abu Dhabi (3) · Roche (3) · Sanofi (3) · Taiba Healthcare (3) · Tabuk Pharmaceuticals (3) · Dar Al Dawa (3) · Kazakhstan Ministry of Health (3) · Galenicum (2) · DKSH (2) · Laprophan (2) · Adalvo (2) · Eva Pharma (2) · Rameda (2) · Menarini (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · JCR Pharmaceuticals (2) · Gen İlaç (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · SaudiVax (2) · Novo Nordisk (2) · VACSERA (2) · Lifera (2) · Julphar (2)
By therapeutic area
Multi-therapy (34) · Oncology (19) · Metabolic / Diabetes (18) · Cardiovascular (13) · Vaccines (11) · Immunology / Inflammation (8) · Ophthalmology (4) · Rare / Orphan (4) · CNS / Neurology (3) · Consumer health (3) · Infectious Disease (3) · Respiratory (2) · Women's Health (2)